ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Meitheal Recalls Cisatracurium Besylate Injection
February 01, 2021Meitheal Pharmaceuticals is voluntarily recalling one (1) lot of Cisatracurium Besylate Injection, USP 10mg per 5mL to the user level. -
Zydus Cadila Receives FDA Approval for Cisatracurium Besylate Injection
September 07, 2020Zydus Cadila has received final approval from the US Food and Drug Administration (FDA) to market Cisatracurium Besylate Injection USP (US RLD: Nimbex ®) in the strength of 20 mg (base)/10 mL (2 mg/mL) Multiple-Dose Vial. -
Zydus Cadila gets US FDA approval for Cisatracurium Besylate Injection
September 03, 2020Zydus Cadila has received final approval from the USFDA to market Cisatracurium Besylate Injection USP (US RLD: Nimbex) in the strength of 20 mg (base)/10 mL (2 mg/mL) multiple-dose vial.
Pharma Sources Insight January 2025
